Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions
Can diet, microbiome personalization reverse IBD increase?
Key clinical point: Personalized diet may stem the global spread of inflammatory bowel disease.
Major finding: Pouchitis is a viable surrogate for studying diet and microbiome in inflammatory bowel disease.
Study details: A prospective cohort study of an unspecified number of patients with pouchitis.
Disclosures: Dr. Dotan reported financial relationships with AbbVie, Takeda, Pfizer, Genentech/Roche, Neopharm, and Gilead.
Citation:
Dotan I. Crohn’s & Colitis Congress 2020, Presentation Sp75.